endometrial clear cell adenocarcinoma

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +232 more
Jan 12, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +5 more
  • Houston, Texas
  • +6 more
Dec 5, 2022

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma Trial in

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +17 more
  • Birmingham, Alabama
  • +376 more
Aug 24, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer Trial in Canada,

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Baltimore, Maryland
  • +6 more
Apr 25, 2022

Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin

Active, not recruiting
  • Breast Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 28, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v7 Trial in

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +669 more
Sep 28, 2021

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Hartford, Connecticut
  • +21 more
Oct 13, 2020

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +3 more
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Oklahoma City (Mirvetuximab

Withdrawn
  • Endometrial Cancer
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jun 25, 2019

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

Unknown status
  • Endometrial Clear Cell Adenocarcinoma
  • +6 more
  • 3-Dimensional Conformal Radiation Therapy
  • +7 more
  • Birmingham, Alabama
  • +539 more
Mar 8, 2019

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong

Completed
  • Endometrial Adenocarcinoma
  • +11 more
  • Bevacizumab
  • +4 more
  • Berkeley, California
  • +40 more
Feb 15, 2018

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +8 more
  • Brivanib Alaninate
  • Laboratory Biomarker Analysis
  • Aurora, Colorado
  • +34 more
Nov 2, 2017

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United

Completed
  • Endometrial Adenosquamous Carcinoma
  • +10 more
  • Hartford, Connecticut
  • +8 more
Aug 23, 2017

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Doxorubicin Hydrochloride
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Apr 30, 2015

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 29, 2014

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer Trial in Philadelphia

Completed
  • Endometrial Clear Cell Adenocarcinoma
  • +3 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 29, 2014